Percutaneous Transhepatic Direct Portosystemic Shunt for a Patient With Budd-Chiari Syndrome Using a Balloon as a Target in a Stenotic Inferior Vena Cava

por Fujiwara, Kisako, Kondo, Takayuki, Fujimoto, Kentaro, Koizumi, Jun, Kato, Naoya
Publicado 2023

Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients

por Kondo, Takayuki, Fujiwara, Kisako, Nakagawa, Miyuki, Fujimoto, Kentaro, Yumita, Sae, Ishino, Takamasa, Ogawa, Keita, Iwanaga, Terunao, Koroki, Keisuke, Kanzaki, Hiroaki, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Ogasawara, Sadahisa, Nakamoto, Shingo, Chiba, Tetsuhiro, Kato, Jun, Kato, Naoya
Publicado 2023

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury

por Kondo, Takayuki, Fujimoto, Kentaro, Fujiwara, Kisako, Yumita, Sae, Ishino, Takamasa, Ogawa, Keita, Nakagawa, Miyuki, Iwanaga, Terunao, Koroki, Keisuke, Kanzaki, Hiroaki, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Ogasawara, Sadahisa, Nakamoto, Shingo, Chiba, Tetsuhiro, Kato, Jun, Fujiwara, Keiichi, Kato, Naoya
Publicado 2023

The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma

por Kondo, Takayuki, Fujiwara, Kisako, Nakagawa, Miyuki, Unozawa, Hidemi, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Koroki, Keisuke, Kanzaki, Hiroaki, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Kato, Naoya
Publicado 2022

Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus

por Ma, Yaojia, Nakamoto, Shingo, Ao, Junjie, Qiang, Na, Kogure, Tadayoshi, Ogawa, Keita, Nakagawa, Miyuki, Fujiwara, Kisako, Iwanaga, Terunao, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Nakagawa, Ryo, Ogasawara, Sadahisa, Muroyama, Ryosuke, Chiba, Tetsuhiro, Kato, Jun, Kato, Naoya
Publicado 2022

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial

por Ogasawara, Sadahisa, Koroki, Keisuke, Makishima, Hirokazu, Wakatsuki, Masaru, Takahashi, Asahi, Yumita, Sae, Nakagawa, Miyuki, Ishino, Takamasa, Ogawa, Keita, Fujiwara, Kisako, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Kojima, Ryuta, Kanzaki, Hiroaki, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Nakagawa, Ryo, Nakamoto, Shingo, Muroyama, Ryosuke, Chiba, Tetsuhiro, Ozawa, Yoshihito, Kawasaki, Yohei, Kurokawa, Tomoya, Hanaoka, Hideki, Tsuji, Hiroshi, Kato, Naoya
Publicado 2022

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

por Kanogawa, Naoya, Ogasawara, Sadahisa, Maruta, Susumu, Iino, Yotaro, Obu, Masamichi, Ishino, Takamasa, Ogawa, Keita, Yumita, Sae, Iwanaga, Terunao, Unozawa, Hidemi, Nakagawa, Miyuki, Fujiwara, Kisako, Sakuma, Takafumi, Fujita, Naoto, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Inoue, Masanori, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Nakamoto, Shingo, Muroyama, Ryosuke, Chiba, Tetsuhiro, Itobayashi, Ei, Koma, Yoshihiro, Azemoto, Ryosaku, Kato, Jun, Kato, Naoya
Publicado 2023

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment

por Mukai, Shohei, Kanzaki, Hiroaki, Ogasawara, Sadahisa, Ishino, Takamasa, Ogawa, Keita, Nakagawa, Miyuki, Fujiwara, Kisako, Unozawa, Hidemi, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Koroki, Keisuke, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Suzuki, Eiichiro, Ooka, Yoshihiko, Muroyama, Ryosuke, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Shiina, Manayu, Ota, Masayuki, Ikeda, Jun‐ichiro, Takiguchi, Yuichi, Ohtsuka, Masayuki, Kato, Naoya
Publicado 2021

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience

por Ogawa, Keita, Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Qiang, Na, Ma, Yaojia, Zhang, Jiaqi, Yumita, Sae, Ishino, Takamasa, Unozawa, Hidemi, Kan, Motoyasu, Iwanaga, Terunao, Nakagawa, Miyuki, Fujiwara, Kisako, Fujita, Naoto, Sakuma, Takafumi, Koroki, Keisuke, Kusakabe, Yuko, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Ogasawara, Sadahisa, Suzuki, Eiichiro, Nakamoto, Shingo, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Mimura, Naoya, Kato, Jun, Motohashi, Shinichiro, Kato, Naoya
Publicado 2022

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

por Yumita, Sae, Ogasawara, Sadahisa, Nakagawa, Miyuki, Maruta, Susumu, Okubo, Tomomi, Itokawa, Norio, Iino, Yotaro, Obu, Masamichi, Haga, Yuki, Seki, Atsuyoshi, Kogure, Tadayoshi, Ishino, Takamasa, Ogawa, Keita, Fujiwara, Kisako, Iwanaga, Terunao, Fujita, Naoto, Sakuma, Takafumi, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Nakagawa, Ryo, Nakamoto, Shingo, Muroyama, Ryosuke, Chiba, Tetsuhiro, Itobayashi, Ei, Atsukawa, Masanori, Koma, Yoshihiro, Azemoto, Ryosaku, Ito, Kenji, Mizumoto, Hideaki, Kato, Jun, Kato, Naoya
Publicado 2023